Prevalence and clinical relevance of thyroid autoantibodies in patients with goitre in Nigeria

Abstract

Background: Thyroid autoimmunity was thought to be rare in Africans but there is evidence that its prevalence is increasing. Since undetected autoimmune thyroid disease carries considerable morbidity, this study set out to determine the proportion of patients with goitre who have thyroid autoantibodies and the relationship, if any, between the presence of thyroid autoantibodies, thyroid function and thyroid size. Methods: The study was cross-sectional and conducted over a 12-month period. It involved 100 subjects with goitre and 50 apparently healthy controls without goitre, matched for age and sex. Thyroid dysfunction was assessed by history, clinical examination and biochemical tests, thyroid peroxidase and thyroglobulin antibodies. The size of the thyroid gland was assessed by ultrasound. Results: Fifty-seven percent (57%) of study subjects were euthyroid, 38% were hyperthyroid, while 2% were hypothyroid. The overall prevalence of elevated thyroid peroxidase antibody (TPOAb) in the subjects with goitre was 35% and 8% in the controls (p < 0.001). Elevated thyroglobulin antibody (TgAb) was found in 24% of subjects with goitre and 12% of controls (p = 0.083). Elevated TPOAb was found in 76.3% of subjects who were hyperthyroid, 7% of subjects who were euthyroid and 100% of subjects who were hypothyroid (p < 0.001). Elevated TgAb level was present in 36.8%, 15.8% and 50% of subjects with hyperthyroid, euthyroid and hypothyroid goitre respectively (p = 0.068). A positive correlation was observed between TPOAb and erythrocyte sedimentation rate (r = 0.582, p < 0.001) and TgAb and erythrocyte sedimentation rate (r = 0.176, p = 0.08). The correlation between TPOAb and thyroid volume (r = -0.139, p = 0.167) and that of TgAb and thyroid volume (r = -0.119, p = 0.238) was not significant. Conclusion:The prevalence of thyroid autoantibodies in patients with goitre is high in Nigeria. Thyroid peroxidase antibody is more prevalent than thyroglobulin antibody in thyroid disorders and appears to be a better marker than thyroglobulin antibody in detecting autoimmune thyroid dysfunction.

To study the prevalence of thyroid autoimmune antibody in chronic kidney disease patients with hypothyroidism in Eastern Uttar Pradesh

“…In our study, the mean (SD) age at which hypothyroidism occurred was 40.70 ±14.31 years in the control group. These observations were consistent with earlier studies of thyroid disorders conducted by Ogbera et al in Lagos, Ojo et al 19 in Ile-Ife, Chehade et al 20 in the United States, and McGrogan et al 18 in Nigeria, who discovered a mean age of 40 ±12.4 years, 42.7± 12.6 years, 47.8± 14.9 years, and 44.6 ±13.8 years, respectively.…”

Investigation of Parvovirus B19 in Hashimoto thyroiditis

“…These results are similar to the results of a study that showed the presence of anti-TPO antibody in hypothyroidism was 100%, while hyperthyroidism was 76.3% and euthyroidism was 7%. (Ojo et al, 2019). Moreover, it was found that the highest percentage of patients with anti-TPO antibodies in the hypothyroidism group was 71.40%, which may indicate a higher risk of HT.…”

Safe Thyroidectomy in Low- and Middle-Income Countries

“…Graves' disease is becoming more prevalent in African areas, which are transitioning from iodine deficient to iodine sufficient. The prevalence of autoimmune hypothyroid disorders is low, compared to European or North American countries [8]. With the absence of laboratory testing, thyrotoxicosis should be suspected when there is a combination of thyroid enlargement (diffuse or nodular) and clinical signs of hyperthyroidism, such as loss of weight, tremor, sweating, anxiety, hyperactivity, palpitations, tachycardia or exophthalmos.…”